Neo Ivy Capital Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Sell |
1,419
-5,553
| -80% | -$408K | 0.03% | 292 |
|
|
2025
Q1 | $796K | Buy |
+6,972
| New | +$796K | 0.25% | 130 |
|
|
2023
Q4 | – | Sell |
-2,424
| Closed | -$66K | – | 318 |
|
|
2023
Q3 | $66K | Sell |
2,424
-2,178
| -47% | -$59.3K | 0.03% | 270 |
|
|
2023
Q2 | $102K | Buy |
+4,602
| New | +$102K | 0.05% | 237 |
|
|
2022
Q4 | $453K | Buy |
22,314
+22,255
| +37,720% | +$452K | 0.31% | 166 |
|
|
2022
Q3 | $2K | Buy |
+59
| New | +$2K | 0.01% | 357 |
|
|
2022
Q2 | – | Sell |
-4,980
| Closed | -$112K | – | 439 |
|
|
2022
Q1 | $112K | Buy |
+4,980
| New | +$112K | 0.1% | 289 |
|
|
2021
Q3 | – | Sell |
-1,529
| Closed | -$34K | – | 494 |
|
|
2021
Q2 | $34K | Sell |
1,529
-11,890
| -89% | -$264K | 0.03% | 346 |
|
|
2021
Q1 | $319K | Buy |
+13,419
| New | +$319K | 0.35% | 99 |
|
|
2020
Q4 | – | Sell |
-510
| Closed | -$8K | – | 441 |
|
|
2020
Q3 | $8K | Buy |
+510
| New | +$8K | 0.01% | 431 |
|